Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRANYLCYPROMINE Cause Product substitution issue? 5 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product substitution issue have been filed in association with TRANYLCYPROMINE (Tranylcypromine). This represents 1.3% of all adverse event reports for TRANYLCYPROMINE.

5
Reports of Product substitution issue with TRANYLCYPROMINE
1.3%
of all TRANYLCYPROMINE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Product substitution issue From TRANYLCYPROMINE?

Of the 5 reports, 1 (20.0%) required hospitalization.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRANYLCYPROMINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does TRANYLCYPROMINE Cause?

Hypertensive crisis (53) Contraindicated product administered (50) Drug interaction (44) Depression (41) Hypertension (39) Headache (33) Drug ineffective (30) Insomnia (30) Serotonin syndrome (30) Dizziness (27)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which TRANYLCYPROMINE Alternatives Have Lower Product substitution issue Risk?

TRANYLCYPROMINE vs TRASTUZUMAB TRANYLCYPROMINE vs TRASTUZUMAB-ANNS TRANYLCYPROMINE vs TRASTUZUMAB DERUXTECAN TRANYLCYPROMINE vs TRASTUZUMAB-DKST TRANYLCYPROMINE vs TRASTUZUMAB-DTTB

Related Pages

TRANYLCYPROMINE Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue TRANYLCYPROMINE Demographics